content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>As filed with the Securities and Exchange Commission on September
  20, 2024</B></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
  
  <!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>
  
  <P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">UNITED STATES<BR>
  SECURITIES AND EXCHANGE COMMISSION<BR>
  </FONT><FONT STYLE="font-size: 10pt">Washington, D.C. 20549</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"></FONT></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM S-8<BR>
  REGISTRATION STATEMENT</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><I>UNDER<BR>
  THE SECURITIES ACT OF 1933</I></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>
  
  <P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt">Moolec Science
  SA<BR>
  </FONT></P>
  
  <P STYLE="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 50%; font-size: 12pt; text-align: center; font-weight: bold"><FONT STYLE="font-size: 10pt">Grand Duchy of Luxembourg<BR>
  (State or other jurisdiction of<BR>
  incorporation or organization)</FONT></TD>
      <TD STYLE="width: 50%; font-size: 12pt; text-align: center; font-weight: bold"><FONT STYLE="font-size: 10pt">Not Applicable<BR>
  (I.R.S. Employer<BR>
  Identification No.)</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><B>17, Boulevard F. W. Raiffeisen</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><B>L-2411 Luxembourg,</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><B>Grand Duchy of Luxembourg<BR>
  (Address of principal executive offices) (Zip code)</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.3in"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.3in"><B>2024 Incentive Plan</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.3in"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.3in"><B>(Full title of the plan)</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Cogency Global Inc.<BR>
  122 East 42nd Street, 18th Floor<BR>
  New York, NY 10168<BR>
  (212) 947-7200<BR>
  (Name and address of agent for service) (Telephone number, including area code, of agent for service)</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"></FONT></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><B><I>Copies to</I></B>:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%">
      <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Matthew S. Poulter, Esq.<BR>
      Andrew Gaines, Esq.</P>
      <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Linklaters LLP<BR>
      1290 Avenue of the Americas<BR>
      New York, NY 10104<BR>
      Phone: (212) 903-9000<BR>
      Fax: (212) 903-9100</P></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Indicate by check mark whether
  the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging
  growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting
  company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 25%; text-align: left; font-weight: bold"><FONT STYLE="font-size: 10pt; font-weight: normal">Large accelerated filer</FONT></TD>
      <TD STYLE="width: 25%; text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9744;</FONT></TD>
      <TD STYLE="width: 25%; text-align: left; font-weight: bold"><FONT STYLE="font-size: 10pt; font-weight: normal">Accelerated filer</FONT></TD>
      <TD STYLE="width: 25%; text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9744;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left; font-weight: bold"><FONT STYLE="font-size: 10pt; font-weight: normal">Non-accelerated filer</FONT></TD>
      <TD STYLE="text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9746;</FONT></TD>
      <TD STYLE="text-align: left; font-weight: bold"><FONT STYLE="font-size: 10pt; font-weight: normal">Smaller reporting company</FONT></TD>
      <TD STYLE="text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9744;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left; font-weight: bold"><FONT STYLE="font-size: 10pt; font-weight: normal">Emerging growth company</FONT></TD>
      <TD STYLE="text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9746;</FONT></TD>
      <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD>
      <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If an emerging growth company,
  indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
  accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXPLANATORY NOTE</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This registration statement
  on Form S-8 is being filed by Moolec Science SA, a public limited liability company (<I>soci&eacute;t&eacute; anonyme</I>) governed by
  the laws of the Grand Duchy of Luxembourg, having its registered office at 17, Boulevard F.W. Raiffeisen, L-2411 Luxembourg, Grand Duchy
  of Luxembourg and registered with the Luxembourg Trade and Companies&rsquo; Register (<I>Registre de Commerce et des Soci&eacute;t&eacute;s,
  Luxembourg</I>) under number B268440 (the &ldquo;Registrant&rdquo;, the &ldquo;Company&rdquo;, or &ldquo;we&rdquo;), for the purpose of
  registering 12,000,000 ordinary shares of the Company, with a nominal value of $0.01 per share (the &ldquo;Ordinary Shares&rdquo;),
  initially issuable under the 2024 Incentive Plan (the &ldquo;2024 Plan&rdquo;).</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 18,
  2024, our board of directors approved the 2024 Plan, pursuant to which we amended and restated our Employee Share Plan in its entirety.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">PART I</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INFORMATION REQUIRED
  IN THE SECTION&#8239;10(A)&#8239;PROSPECTUS</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information specified
  in Part&#8239;I of Form&#8239;S-8 is omitted from this Registration Statement in accordance with the provisions of Rule&#8239;428 under
  the Securities Act and the introductory note to Part&#8239;I of Form&#8239;S-8. The documents containing the information specified in
  Part&#8239;I of Form&#8239;S-8 will be delivered to the participant in the plans covered by this Registration Statement as specified by
  Rule&#8239;428(b)(1)&#8239;under the Securities Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">PART II</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INFORMATION REQUIRED
  IN THE REGISTRATION STATEMENT</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><I>&nbsp;</I></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><I>References in this Registration
  Statement to &ldquo;the &ldquo;Company,&rdquo; &ldquo;the Registrant,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; or
  similar references, are to Moolec Science SA, unless otherwise stated or the context otherwise requires.</I></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><I>&nbsp;</I></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 3.</TD><TD STYLE="text-align: justify">Incorporation of Documents By Reference.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This registration statement
  incorporates important business and financial information about that is not included in or delivered with the registration statement.
  The U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) allows us to &ldquo;incorporate by reference&rdquo; information
  filed with the Commission, which means that we can disclose important information to you by referring you to those documents. The information
  incorporated by reference is considered to be part of this registration statement, and certain later information that we file with the
  Commission will automatically update and supersede this information.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This document incorporates
  by reference the following documents that have previously been filed with the Commission by us:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">our annual report on <A HREF="http://www.sec.gov/Archives/edgar/data/1937737/000121390023082664/f20f2023a1_moolecsci.htm">Form 20-F/A</A> (File No. 001-41586) for the
  year ended June 30, 2023, filed with the Commission on November 2, 2023 (the &ldquo;Annual Report&rdquo;);</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the report on <A HREF="http://www.sec.gov/Archives/edgar/data/1937737/000121390024057118/ea0208570-6k_moolec.htm">Form 6-K</A> furnished to the Commission on June 28, 2024 containing our unaudited interim
                                                                                         condensed consolidated Financial Statements as of March 31, 2024 and June 30, 2023, and for the nine months ended March 31, 2024 and
                                                                                         2023, prepared and presented in accordance with IAS 34 &ndash; &ldquo;Interim Financial Reporting&rdquo; as issued by the
                                                                                         International Accounting Standards Board; and</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any of future filings made with the Commission after the date
  of this registration statement, and any future reports on Form 6-K furnished to the Commission pursuant to Section 13(a) or 15(d) of
  the United States Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) after the date of this registration statement
  that are identified in those forms as being incorporated by reference into this registration statement.</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All other reports and documents
  subsequently filed (but not furnished) by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date
  of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that
  all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated
  by reference herein and to be a part hereof from the date of filing of such reports and documents.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Any statement contained
  in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein
  shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein
  or in any subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to be incorporated
  by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as
  so modified or superseded, to constitute a part of this Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under no circumstances shall
  any information subsequently furnished on Form 6-K be deemed incorporated herein by reference unless such Form 6-K expressly provides
  to the contrary.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 4.</TD><TD STYLE="text-align: justify">Description of Securities.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 5.</TD><TD STYLE="text-align: justify">Interests of Named Experts and Counsel.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></P>
  
  <!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 6.</TD><TD STYLE="text-align: justify">Indemnification of Directors and Officers.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The amended and restated
  articles of association adopted in connection with the business combination, which was consummated on December 30, 2022 (the &ldquo;Business
  Combination&rdquo;), and the current version amended and restated articles of association dated 23 May 2024 (the &ldquo;Articles&rdquo;),
  contain specific indemnification provisions stating that every person who is, or has been, a member of our board of directors or officer
  (<I>mandataire</I>) shall be indemnified by us to the fullest extent permitted by Luxembourg law against liability and against all expenses
  reasonably incurred or paid by such director or officer in connection with any claim, action, suit or proceeding in which such director
  or officer becomes involved as a party or otherwise by virtue of his or her being or having been a director or officer of the Company,
  or, at the request of the Company, of any other company of which the Company is a shareholder or creditor and by which he is not entitled
  to be indemnified, and against amounts paid or incurred by him or her in the settlement thereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Articles provide further
  that no indemnification will be provided to any director or officer (i) against any liability by reason of willful misfeasance, bad faith,
  gross negligence or reckless disregard of the duties involved in the conduct of his or her office, (ii) with respect to any matter as
  to which he or she shall have been finally adjudicated to have acted in bad faith and not in the interest of the Company or (iii) in the
  event of a settlement, unless the settlement has been approved by a court of competent jurisdiction or by the board of directors of the
  Company. The right of indemnification provided under the Articles shall be severable, shall not affect any other rights to which any director
  or officer may now or hereafter be entitled, shall continue as to a person who has ceased to be such director or officer and shall inure
  to the benefit of the heirs, executors and administrators of such a person. Nothing contained in the Articles shall affect or limit any
  rights to indemnification to which corporate personnel, including directors and officers, may be entitled by contract or otherwise under
  law. The Company shall specifically be entitled to provide contractual indemnification to and may purchase and maintain insurance for
  any corporate personnel, including directors and officers of the Company, as the Company may decide upon from time to time.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Further, in connection with
  the consummation of the Business Combination, we entered into indemnification agreements with each of our directors and executive officers.
  These agreements provide that the director or officer will be indemnified by us to the fullest extent permitted by law against liability
  and against all expenses reasonably incurred or paid by him or her in connection with any claim, action, suit or proceeding which he or
  she becomes involved as a party or otherwise by virtue of his or her being or having been such a director or officer of and against amounts
  paid or incurred by him or her in the resolution thereof. The agreements are subject to certain exceptions, including, among other exceptions,
  that no indemnification will be provided to any director or officer against any liability to us or our shareholders (i) by reason of actual
  fraud, dishonesty, actual fraudulent conduct, or gross negligence on the part of the director or officer; (ii) by reason of payment made
  under an insurance policy or any third party that has no recourse against the indemnitee director or officer; or (iii) if contrary to
  applicable law.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The rights to and obligations
  of indemnification among or between us and any of our current or former directors and officers are generally governed by the laws of Luxembourg
  and subject to the jurisdiction of the Luxembourg courts, unless such rights or obligations do not relate to or arise out of such persons&rsquo;
  capacities listed above.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 7.</TD><TD STYLE="text-align: justify">Exemption From Registration Claimed.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></P>
  
  <!-- Field: Page; Sequence: 5; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 8.</TD><TD STYLE="text-align: justify">Exhibits.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-indent: 0in"><B>Exhibit No.</B></TD>
      <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; width: 90%; text-indent: 0in"><B>Description</B></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="text-indent: 0in">3.1*</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/1937737/000121390022074033/ff42022a1ex3-1_moolec.htm">Amended and Restated Articles of Association of Moolec Science SA, dated December 29, 2022, (incorporated herein by reference to Exhibit 1.1 to the Company&rsquo;s Annual Report on Form 20-F/A for the year ended December 31, 2023 (File No. 001-41586) filed on November 2, 2023).</A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD STYLE="text-indent: 0in">5.1**</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="ea021477501ex5-1_moolec.htm">Opinion of Linklaters LLP, Luxembourg.</A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="text-indent: 0in">23.1**</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="ea021477501ex23-1_moolec.htm">Consent of Price Waterhouse &amp; Co. S.R.L., independent registered public accounting firm, with respect to Moolec Science SA&rsquo;s consolidated financial statements.</A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD STYLE="text-indent: 0in">23.3**</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="ea021477501ex5-1_moolec.htm">Consent Linklaters LLP, Luxembourg (included in Exhibit 5.1).</A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="text-indent: 0in">24.1**</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="#poa">Power of Attorney (included on the signature page of this Registration Statement).</A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
      <TD STYLE="text-indent: 0in">99.1**</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="ea021477501ex99-1_moolec.htm">2024 Incentive Plan.</A></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD STYLE="text-indent: 0in">107**</TD>
      <TD STYLE="text-indent: 0in">&nbsp;</TD>
      <TD STYLE="text-align: justify; text-indent: 0in"><A HREF="ea021477501ex-fee_moolec.htm">Filing Fee Table.</A></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><I>&nbsp;</I></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><I></I></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><I></I></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <I>Note:&mdash;</I></P>
  
  
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Previously filed.</TD>
  </TR></TABLE>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">**</TD><TD STYLE="text-align: justify">Filed herewith.</TD>
  </TR></TABLE>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in">Item 9.</TD><TD STYLE="text-align: justify">Undertakings.</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) The undersigned Registrant hereby undertakes:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(1) To file, during any period in which
  offers or sales are being made, a post-effective amendment to this Registration Statement:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i) To include any prospectus required
  by Section 10(a)(3) of the Securities Act;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii) To reflect in the prospectus any
  facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which,
  individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding
  the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
  that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
  form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no
  more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the
  effective Registration Statement; and</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iii) To include any material information
  with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information
  in the Registration Statement;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">provided, however, that paragraphs (a)(1)(i)
  and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
  in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange
  Act that are incorporated by reference in the Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(2) That, for the purpose of determining
  any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating
  to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
  thereof; and</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(3) To remove from registration by means
  of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned Registrant hereby undertakes
  that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&rsquo;s annual report pursuant
  to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report
  pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a
  new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
  to be the initial bona fide offering thereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
  arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing
  provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public
  policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
  liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
  Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in
  connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
  by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
  policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 6; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SIGNATURES</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
  of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
  requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
  duly authorized, in the Rosario, Argentina, on this 20th day of September, 2024.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left"><B>&nbsp;</B></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD COLSPAN="3" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Moolec Science
      SA</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 31%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
      <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
      Gast&oacute;n Paladini</FONT>
  
  <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&oacute;n Paladini</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and
      Executive Director</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.75in; text-align: left; text-indent: -0.25in">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 7; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="poa"></A>POWER OF ATTORNEY</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We, the undersigned directors
  and officers of Moolec Science SA, hereby severally constitute and appoint Gast&oacute;n Paladini and Jos&eacute; L&oacute;pez Lecube
  each of them singly, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution for
  him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including any post-effective
  amendments) to this registration statement, and any subsequent registration statements pursuant to Rule&nbsp;462 of the United States
  Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with
  the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to
  do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and
  purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact or his or her substitute
  or substitutes, may lawfully do or cause to be done by virtue hereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
  of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and
  on the dates indicated.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
      <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 51%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
      <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Gast&oacute;n Paladini
  
  <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
      <TD>&nbsp;</TD>
      <TD>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer and Executive Director</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 20, 2024</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&oacute;n Paladini</FONT></TD>
      <TD>&nbsp;</TD>
      <TD>(<I>Principal Executive Officer</I>)</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD></TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">/s/ Jos&eacute; L&oacute;pez Lecube</P>
  
  <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P></TD>
      <TD>&nbsp;</TD>
      <TD>Chief Financial Officer and Executive Director</TD>
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 20, 2024</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jos&eacute; L&oacute;pez Lecube</FONT></TD>
      <TD>&nbsp;</TD>
      <TD>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>(<I>Principal Financial and Accounting Officer</I>)</TD>
      <TD>&nbsp;</TD>
      <TD></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD></TD>
      <TD>&nbsp;</TD>
      <TD></TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Natalia Zang
  
  <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
      <TD>&nbsp;</TD>
      <TD>Director</TD>
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 20, 2024</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalia Zang</FONT></TD>
      <TD>&nbsp;</TD>
      <TD></TD>
      <TD>&nbsp;</TD>
      <TD></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Kyle P. Bransfield
  
  <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 20, 2024</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kyle P. Bransfield</FONT></TD>
      <TD>&nbsp;</TD>
      <TD></TD>
      <TD>&nbsp;</TD>
      <TD></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Esteban Guillermo Corley
  
  <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 20, 2024</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Esteban Guillermo Corley</FONT></TD>
      <TD>&nbsp;</TD>
      <TD></TD>
      <TD>&nbsp;</TD>
      <TD></TD></TR>
    </TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 8; Value: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SIGNATURE OF AUTHORIZED
  U.S. REPRESENTATIVE</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the Securities
  Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Moolec Science SA, has signed this
  registration statement on this 20th day of September, 2024.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left"><B>&nbsp;</B></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD COLSPAN="3" STYLE="text-align: left"><B>COGENCY GLOBAL INC.</B></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 60%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 4%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 5%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 31%; text-align: left">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">By:</TD>
      <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left">/s/ Colleen A. De Vries</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">Name:&nbsp;</TD>
      <TD STYLE="text-align: left">Colleen A. De Vries</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">Title:</TD>
      <TD STYLE="text-align: left">Senior Vice President on behalf of Cogency Global Inc.</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify">&nbsp;&nbsp;</P>
  
  <!-- Field: Page; Sequence: 9; Options: Last -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "ea0214775-s8_moolec.htm", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 58812}]
metadata_filer: {"company-data": {"conformed-name": "Moolec Science SA", "cik": "0001937737", "assigned-sic": "6770", "organization-name": "04 Manufacturing", "irs-number": "000000000", "state-of-incorporation": "N4", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-282263", "film-number": "241313721"}, "business-address": {"street1": "17, BOULEVARD F.W. RAIFFEISAN", "city": "LUXEMBOURG", "state": "N4", "zip": "L-2411", "phone": "352 26 49 65 65"}, "mail-address": {"street1": "17, BOULEVARD F.W. RAIFFEISAN", "city": "LUXEMBOURG", "state": "N4", "zip": "L-2411"}}
text: As filed with the Securities and Exchange Commission on September
  20, 2024
  Registration No. 333-
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM S-8
  REGISTRATION STATEMENT
  UNDER
  THE SECURITIES ACT OF 1933
  Moolec Science
  SA
  (Exact name of registrant as specified in its charter)
  Grand Duchy of Luxembourg
  (State or other jurisdiction of
  incorporation or organization)
  Not Applicable
  (I.R.S. Employer
  Identification No.)
  17, Boulevard F. W. Raiffeisen
  L-2411 Luxembourg,
  Grand Duchy of Luxembourg
  (Address of principal executive offices) (Zip code)
  2024 Incentive Plan
  (Full title of the plan)
  Cogency Global Inc.
  122 East 42nd Street, 18th Floor
  New York, NY 10168
  (212) 947-7200
  (Name and address of agent for service) (Telephone number, including area code, of agent for service)
  Copies to
  :
  Matthew S. Poulter, Esq.
  Andrew Gaines, Esq.
  Linklaters LLP
  1290 Avenue of the Americas
  New York, NY 10104
  Phone: (212) 903-9000
  Fax: (212) 903-9100
  Indicate by check mark whether
  the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging
  growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting
  company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
  Large accelerated filer
  ☐
  Accelerated filer
  ☐
  Non-accelerated filer
  ☒
  Smaller reporting company
  ☐
  Emerging growth company
  ☒
  If an emerging growth company,
  indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
  accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
  ☐
  EXPLANATORY NOTE
  This registration statement
  on Form S-8 is being filed by Moolec Science SA, a public limited liability company (
  société anonyme
  ) governed by
  the laws of the Grand Duchy of Luxembourg, having its registered office at 17, Boulevard F.W. Raiffeisen, L-2411 Luxembourg, Grand Duchy
  of Luxembourg and registered with the Luxembourg Trade and Companies' Register (
  Registre de Commerce et des Sociétés,
  Luxembourg
  ) under number B268440 (the "Registrant", the "Company", or "we"), for the purpose of
  registering 12,000,000 ordinary shares of the Company, with a nominal value of $0.01 per share (the "Ordinary Shares"),
  initially issuable under the 2024 Incentive Plan (the "2024 Plan").
  On September 18,
  2024, our board of directors approved the 2024 Plan, pursuant to which we amended and restated our Employee Share Plan in its entirety.
  PART I
  INFORMATION REQUIRED
  IN THE SECTION 10(A) PROSPECTUS
  The information specified
  in Part I of Form S-8 is omitted from this Registration Statement in accordance with the provisions of Rule 428 under
  the Securities Act and the introductory note to Part I of Form S-8. The documents containing the information specified in
  Part I of Form S-8 will be delivered to the participant in the plans covered by this Registration Statement as specified by
  Rule 428(b)(1) under the Securities Act.
  1
  PART II
  INFORMATION REQUIRED
  IN THE REGISTRATION STATEMENT
  References in this Registration
  Statement to "the "Company," "the Registrant," "we," "us," "our," or
  similar references, are to Moolec Science SA, unless otherwise stated or the context otherwise requires.
  Item 3.
  Incorporation of Documents By Reference.
  This registration statement
  incorporates important business and financial information about that is not included in or delivered with the registration statement.
  The U.S. Securities and Exchange Commission (the "Commission") allows us to "incorporate by reference" information
  filed with the Commission, which means that we can disclose important information to you by referring you to those documents. The information
  incorporated by reference is considered to be part of this registration statement, and certain later information that we file with the
  Commission will automatically update and supersede this information.
  This document incorporates
  by reference the following documents that have previously been filed with the Commission by us:
  ●
  our annual report on
  Form 20-F/A
  (File No. 001-41586) for the
  year ended June 30, 2023, filed with the Commission on November 2, 2023 (the "Annual Report");
  ●
  the report on
  Form 6-K
  furnished to the Commission on June 28, 2024 containing our unaudited interim
                                                                                         condensed consolidated Financial Statements as of March 31, 2024 and June 30, 2023, and for the nine months ended March 31, 2024 and
                                                                                         2023, prepared and presented in accordance with IAS 34 – "Interim Financial Reporting" as issued by the
                                                                                         International Accounting Standards Board; and
  ●
  any of future filings made with the Commission after the date
  of this registration statement, and any future reports on Form 6-K furnished to the Commission pursuant to Section 13(a) or 15(d) of
  the United States Securities Exchange Act of 1934, as amended (the "Exchange Act") after the date of this registration statement
  that are identified in those forms as being incorporated by reference into this registration statement.
  All other reports and documents
  subsequently filed (but not furnished) by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date
  of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that
  all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated
  by reference herein and to be a part hereof from the date of filing of such reports and documents.
  Any statement contained
  in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein
  shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein
  or in any subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to be incorporated
  by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as
  so modified or superseded, to constitute a part of this Registration Statement.
  Under no circumstances shall
  any information subsequently furnished on Form 6-K be deemed incorporated herein by reference unless such Form 6-K expressly provides
  to the contrary.
  Item 4.
  Description of Securities.
  Not applicable.
  Item 5.
  Interests of Named Experts and Counsel.
  Not applicable.
  II-
  1
  Item 6.
  Indemnification of Directors and Officers.
  The amended and restated
  articles of association adopted in connection with the business combination, which was consummated on December 30, 2022 (the "Business
  Combination"), and the current version amended and restated articles of association dated 23 May 2024 (the "Articles"),
  contain specific indemnification provisions stating that every person who is, or has been, a member of our board of directors or officer
  (
  mandataire
  ) shall be indemnified by us to the fullest extent permitted by Luxembourg law against liability and against all expenses
  reasonably incurred or paid by such director or officer in connection with any claim, action, suit or proceeding in which such director
  or officer becomes involved as a party or otherwise by virtue of his or her being or having been a director or officer of the Company,
  or, at the request of the Company, of any other company of which the Company is a shareholder or creditor and by which he is not entitled
  to be indemnified, and against amounts paid or incurred by him or her in the settlement thereof.
  The Articles provide further
  that no indemnification will be provided to any director or officer (i) against any liability by reason of willful misfeasance, bad faith,
  gross negligence or reckless disregard of the duties involved in the conduct of his or her office, (ii) with respect to any matter as
  to which he or she shall have been finally adjudicated to have acted in bad faith and not in the interest of the Company or (iii) in the
  event of a settlement, unless the settlement has been approved by a court of competent jurisdiction or by the board of directors of the
  Company. The right of indemnification provided under the Articles shall be severable, shall not affect any other rights to which any director
  or officer may now or hereafter be entitled, shall continue as to a person who has ceased to be such director or officer and shall inure
  to the benefit of the heirs, executors and administrators of such a person. Nothing contained in the Articles shall affect or limit any
  rights to indemnification to which corporate personnel, including directors and officers, may be entitled by contract or otherwise under
  law. The Company shall specifically be entitled to provide contractual indemnification to and may purchase and maintain insurance for
  any corporate personnel, including directors and officers of the Company, as the Company may decide upon from time to time.
  Further, in connection with
  the consummation of the Business Combination, we entered into indemnification agreements with each of our directors and executive officers.
  These agreements provide that the director or officer will be indemnified by us to the fullest extent permitted by law against liability
  and against all expenses reasonably incurred or paid by him or her in connection with any claim, action, suit or proceeding which he or
  she becomes involved as a party or otherwise by virtue of his or her being or having been such a director or officer of and against amounts
  paid or incurred by him or her in the resolution thereof. The agreements are subject to certain exceptions, including, among other exceptions,
  that no indemnification will be provided to any director or officer against any liability to us or our shareholders (i) by reason of actual
  fraud, dishonesty, actual fraudulent conduct, or gross negligence on the part of the director or officer; (ii) by reason of payment made
  under an insurance policy or any third party that has no recourse against the indemnitee director or officer; or (iii) if contrary to
  applicable law.
  The rights to and obligations
  of indemnification among or between us and any of our current or former directors and officers are generally governed by the laws of Luxembourg
  and subject to the jurisdiction of the Luxembourg courts, unless such rights or obligations do not relate to or arise out of such persons'
  capacities listed above.
  Item 7.
  Exemption From Registration Claimed.
  Not applicable.
  II-
  2
  Item 8.
  Exhibits.
  Exhibit No.
  Description
  3.1*
  Amended and Restated Articles of Association of Moolec Science SA, dated December 29, 2022, (incorporated herein by reference to Exhibit 1.1 to the Company's Annual Report on Form 20-F/A for the year ended December 31, 2023 (File No. 001-41586) filed on November 2, 2023).
  5.1**
  Opinion of Linklaters LLP, Luxembourg.
  23.1**
  Consent of Price Waterhouse & Co. S.R.L., independent registered public accounting firm, with respect to Moolec Science SA's consolidated financial statements.
  23.3**
  Consent Linklaters LLP, Luxembourg (included in Exhibit 5.1).
  24.1**
  Power of Attorney (included on the signature page of this Registration Statement).
  99.1**
  2024 Incentive Plan.
  107**
  Filing Fee Table.
  Note:—
  *
  Previously filed.
  **
  Filed herewith.
  Item 9.
  Undertakings.
  (a) The undersigned Registrant hereby undertakes:
  (1) To file, during any period in which
  offers or sales are being made, a post-effective amendment to this Registration Statement:
  (i) To include any prospectus required
  by Section 10(a)(3) of the Securities Act;
  (ii) To reflect in the prospectus any
  facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which,
  individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding
  the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
  that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
  form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no
  more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the
  effective Registration Statement; and
  (iii) To include any material information
  with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information
  in the Registration Statement;
  provided, however, that paragraphs (a)(1)(i)
  and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
  in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange
  Act that are incorporated by reference in the Registration Statement.
  (2) That, for the purpose of determining
  any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating
  to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
  thereof; and
  (3) To remove from registration by means
  of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
  (b) The undersigned Registrant hereby undertakes
  that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant
  to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report
  pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a
  new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
  to be the initial bona fide offering thereof.
  (c) Insofar as indemnification for liabilities
  arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing
  provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public
  policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
  liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
  Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in
  connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
  by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
  policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
  II-
  3
  SIGNATURES
  Pursuant to the requirements
  of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
  requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
  duly authorized, in the Rosario, Argentina, on this 20th day of September, 2024.
  Moolec Science
      SA
  By:
  /s/
      Gastón Paladini
  Name:
  Gastón Paladini
  Title:
  Chief Executive Officer and
      Executive Director
  II-
  4
  POWER OF ATTORNEY
  We, the undersigned directors
  and officers of Moolec Science SA, hereby severally constitute and appoint Gastón Paladini and José López Lecube
  each of them singly, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution for
  him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including any post-effective
  amendments) to this registration statement, and any subsequent registration statements pursuant to Rule 462 of the United States
  Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with
  the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to
  do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and
  purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact or his or her substitute
  or substitutes, may lawfully do or cause to be done by virtue hereof.
  Pursuant to the requirements
  of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and
  on the dates indicated.
  Signature
  Title
  Date
  /s/ Gastón Paladini
  Chief Executive Officer and Executive Director
  September 20, 2024
  Gastón Paladini
  (
  Principal Executive Officer
  )
  /s/ José López Lecube
  Chief Financial Officer and Executive Director
  September 20, 2024
  José López Lecube
  (
  Principal Financial and Accounting Officer
  )
  /s/ Natalia Zang
  Director
  September 20, 2024
  Natalia Zang
  /s/ Kyle P. Bransfield
  Director
  September 20, 2024
  Kyle P. Bransfield
  /s/ Esteban Guillermo Corley
  Director
  September 20, 2024
  Esteban Guillermo Corley
  II-
  5
  SIGNATURE OF AUTHORIZED
  U.S. REPRESENTATIVE
  Pursuant to the Securities
  Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Moolec Science SA, has signed this
  registration statement on this 20th day of September, 2024.
  COGENCY GLOBAL INC.
  By:
  /s/ Colleen A. De Vries
  Name:
  Colleen A. De Vries
  Title:
  Senior Vice President on behalf of Cogency Global Inc.
  II-
  6